bethanechol has been researched along with darifenacin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ouyang, A; Tandon, T; Wrzos, HF | 1 |
Cohen, S; Del Galdo, F; DiMarino, AJ; Jimenez, SA; Mehendiratta, V; Rattan, S; Singh, J | 1 |
1 review(s) available for bethanechol and darifenacin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for bethanechol and darifenacin
Article | Year |
---|---|
Mechanisms mediating cholinergic antral circular smooth muscle contraction in rats.
Topics: Anesthetics, Local; Animals; Benzofurans; Bethanechol; Calcium; Calcium Channel Blockers; Cholinergic Agonists; Dose-Response Relationship, Drug; GTP-Binding Proteins; In Vitro Techniques; Male; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Nifedipine; Pertussis Toxin; Pirenzepine; Pyloric Antrum; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Signal Transduction; Tetrodotoxin | 2004 |
Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Anal Canal; Animals; Autoantibodies; Benzofurans; Bethanechol; Case-Control Studies; Dose-Response Relationship, Drug; Female; Humans; Immunoglobulins; In Vitro Techniques; Male; Middle Aged; Muscarinic Agonists; Muscarinic Antagonists; Muscle Contraction; Myocytes, Smooth Muscle; Phenylephrine; Piperidines; Potassium Chloride; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M3; Scleroderma, Systemic | 2009 |